Short-term effect of winter air pollution on respiratory health of asthmatic children in Paris. 1998

C Segala, and B Fauroux, and J Just, and L Pascual, and A Grimfeld, and F Neukirch
Institut National de la Santé et de la Recherche Médicale, Unité 408, Epidémiologie, Faculté de Médecine, Bichat, Paris, France.

There is controversy as to whether low levels of air pollution affect the symptoms and lung function in asthma. We addressed this by examining the short-term effects of winter air pollution on childhood asthma in Paris. We performed a 6 month follow-up of 84 medically diagnosed asthmatic children classified into two groups of severity. The outcomes included incidence and prevalence of asthma attacks, symptoms and use of supplementary beta2-agonists, peak expiratory flow (PEF) value and its variability. The statistical analysis controlled the lack of independence between daily health outcomes, trends and meteorology. Air pollution was associated with an increase in reports and duration of asthma attacks and asthma-like symptoms in mild asthmatic children. The strongest association was the risk of asthma attack for an increase of 50 microg x m(-3) of sulphur dioxide (SO2) on the same day (odds ratio (OR)=2.86). Maximum reduction in morning peak expiratory flow (PEF) (5%) and maximum increase in PEF variability (2%) were observed at a lag of 3 days for an increase of 50 microg x m(-3) of SO2 in the subgroup of mild asthmatics receiving no regular inhaled medication. In moderate asthmatic children, the duration of supplementary beta2-agonist use was strongly associated with air pollution. The general pattern of our results provides evidence of the effect of the low levels of air pollution encountered in Western Europe on symptoms and lung function in childhood asthma.

UI MeSH Term Description Entries
D008297 Male Males
D010297 Paris The capital city of France.
D010366 Peak Expiratory Flow Rate Measurement of the maximum rate of airflow attained during a FORCED VITAL CAPACITY determination. Common abbreviations are PEFR and PFR. Expiratory Peak Flow Rate,Flow Rate, Peak Expiratory,PEFR
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000280 Administration, Inhalation The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000318 Adrenergic beta-Agonists Drugs that selectively bind to and activate beta-adrenergic receptors. Adrenergic beta-Receptor Agonists,beta-Adrenergic Agonists,beta-Adrenergic Receptor Agonists,Adrenergic beta-Agonist,Adrenergic beta-Receptor Agonist,Betamimetics,Receptor Agonists, beta-Adrenergic,Receptors Agonists, Adrenergic beta,beta-Adrenergic Agonist,beta-Adrenergic Receptor Agonist,Adrenergic beta Agonist,Adrenergic beta Agonists,Adrenergic beta Receptor Agonist,Adrenergic beta Receptor Agonists,Agonist, Adrenergic beta-Receptor,Agonist, beta-Adrenergic,Agonist, beta-Adrenergic Receptor,Agonists, Adrenergic beta-Receptor,Agonists, beta-Adrenergic,Agonists, beta-Adrenergic Receptor,Receptor Agonist, beta-Adrenergic,Receptor Agonists, beta Adrenergic,beta Adrenergic Agonist,beta Adrenergic Agonists,beta Adrenergic Receptor Agonist,beta Adrenergic Receptor Agonists,beta-Agonist, Adrenergic,beta-Agonists, Adrenergic,beta-Receptor Agonist, Adrenergic,beta-Receptor Agonists, Adrenergic
D000393 Air Pollutants Any substance in the air which could, if present in high enough concentration, harm humans, animals, vegetation or materials. Substances include GASES; PARTICULATE MATTER; and volatile ORGANIC CHEMICALS. Air Pollutant,Air Pollutants, Environmental,Environmental Air Pollutants,Environmental Pollutants, Air,Air Environmental Pollutants,Pollutant, Air,Pollutants, Air,Pollutants, Air Environmental,Pollutants, Environmental Air

Related Publications

C Segala, and B Fauroux, and J Just, and L Pascual, and A Grimfeld, and F Neukirch
April 1997, The European respiratory journal,
C Segala, and B Fauroux, and J Just, and L Pascual, and A Grimfeld, and F Neukirch
January 1998, Archives of environmental health,
C Segala, and B Fauroux, and J Just, and L Pascual, and A Grimfeld, and F Neukirch
October 2002, The European respiratory journal,
C Segala, and B Fauroux, and J Just, and L Pascual, and A Grimfeld, and F Neukirch
January 1993, The American review of respiratory disease,
C Segala, and B Fauroux, and J Just, and L Pascual, and A Grimfeld, and F Neukirch
April 1996, Journal of epidemiology and community health,
C Segala, and B Fauroux, and J Just, and L Pascual, and A Grimfeld, and F Neukirch
June 1997, American journal of respiratory and critical care medicine,
C Segala, and B Fauroux, and J Just, and L Pascual, and A Grimfeld, and F Neukirch
October 2010, Environmental health perspectives,
C Segala, and B Fauroux, and J Just, and L Pascual, and A Grimfeld, and F Neukirch
January 2008, Environmental research,
C Segala, and B Fauroux, and J Just, and L Pascual, and A Grimfeld, and F Neukirch
February 1994, Environmental research,
C Segala, and B Fauroux, and J Just, and L Pascual, and A Grimfeld, and F Neukirch
August 1996, American journal of respiratory and critical care medicine,
Copied contents to your clipboard!